Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8) establishes lifelong infection and is the etiologic agent underlying primary effusion lymphoma, multicentric Castleman's disease, and Kaposi's sarcoma, an endothelial cell-based angiogenic tumor that remains the most prevalent AIDS-associated malignancy worldwide. Although the site for a definitive latent reservoir(s) remains unclear, KSHV can infect B cells in the oral cavity and express a number of viral proteins capable of modulating B cell signaling and survival. Shedding of KSHV in the saliva is frequent in infected individuals and concentrations are often higher than in the peripheral blood. Further, epidemiologic work implicates saliva as a major source for person-to-person viral transmission with infected tonsillar B cells also providing a potential source of spread to distal sites within individuals. In contrast, KSHV-infected B cells in the peripheral circulation are extremely rare in asymptomatic individuals and only slightly less infrequent in patients with early stages of disease. These observations suggest that KSHV may preferentially infect a subset of B cells present in the lymphatic organs of the oral cavity. Our overarching hypothesis is that oral exposure to KSHV leads to selective infection of a specific subset of human tonsillar B cells, effecting phenotypic and functional changes favorable to viral persistence and predictive of pathologic potential. Very little is known about the critical identity and character of KSHV-susceptible B cells in the oral cavity, the nature of the infection, the mechanism underlying differential tropism, or the characteristics of KSHV-induced changes in B cell phenotype and function. We propose to answer these questions. It is our long-term goal to causally link these changes with the expression of specific viral genes and identify those alterations potentially responsible for initiating and sustaining KSHV pathogenesis.)
The most recently discovered cancer causing human herpesvirus, KSHV, underlies at least three severe diseases, two of which affect a group of critical immune cells called B cells. This virus tends to afflict individuals least able to fightoff infection, including AIDS patients and solid organ transplant recipients. Recent studies indicate that the most likely route of person-to-person transmission of this virus is through saliva and tha B cells in the tonsils may be the major targets that spread the virus within the body. In this gran application, we propose to understand which B cells KSHV targets, the mechanisms underlying B cell infection and, finally, how infection might transform cellular function.
|Anderson, Melissa S; Loftus, Matthew S; Kedes, Dean H (2014) Maturation and vesicle-mediated egress of primate gammaherpesvirus rhesus monkey rhadinovirus require inner tegument protein ORF52. J Virol 88:9111-28|
|Ellison, Thomas J; Kedes, Dean H (2014) Variable episomal silencing of a recombinant herpesvirus renders its encoded GFP an unreliable marker of infection in primary cells. PLoS One 9:e111502|
|Woodson, Evonne N; Anderson, Melissa S; Loftus, Matthew S et al. (2014) Progressive accumulation of activated ERK2 within highly stable ORF45-containing nuclear complexes promotes lytic gammaherpesvirus infection. PLoS Pathog 10:e1004066|
|Woodson, Evonne N; Kedes, Dean H (2012) Distinct roles for extracellular signal-regulated kinase 1 (ERK1) and ERK2 in the structure and production of a primate gammaherpesvirus. J Virol 86:9721-36|
|Hassman, Lynn M; Ellison, Thomas J; Kedes, Dean H (2011) KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J Clin Invest 121:752-68|